CID1231538

CAS No. 354126-20-8

CID1231538( —— )

Catalog No. M24307 CAS No. 354126-20-8

CID1231538 is a potent GPR35 antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 150 In Stock
5MG 132 In Stock
10MG 211 In Stock
25MG 425 In Stock
50MG 613 In Stock
100MG 873 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CID1231538
  • Note
    Research use only, not for human use.
  • Brief Description
    CID1231538 is a potent GPR35 antagonist.
  • Description
    CID1231538 is a potent GPR35 antagonist.
  • In Vitro
    GPR35 has gained special consideration as a result of its association with many diseases including type-2 diabetes, nociceptive pain, inflammation, mild mental retardation syndrome, metabolic disorders, and gastric cancer.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR35
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    354126-20-8
  • Formula Weight
    524.05
  • Molecular Formula
    C26H22ClN3O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (95.41 mM)
  • SMILES
    O=C(NC1=CC=C2N=C(SCC3=CC=C(Cl)C=C3)SC2=C1)C4=CC=CC=C4C(N5CCOCC5)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Abdalhameed MM, et al. Structure-activity relationships of benzothiazole GPR35 antagonists. Bioorg Med Chem Lett. 2017;27(3):612-615.
molnova catalog
related products
  • Latanoprost acid

    Latanoprost acid is a selective agonist of prostanoid receptors and inhibits RANKL-induced osteoclastogenesis and function through the inhibition of c-fos/NFATc1 pathway.

  • YE 120

    YE 120 is a highly potent GPR35 agonist (EC50: 32.5 nM) with potential anti-inflammatory and anti-cancer activities, which can be used to study G protein-coupled receptor-related diseases.

  • PSB-CB5

    PSB-CB5 (GPR18-IN-32)2 is a GRP18 antagonist with anti-inflammatory activity and can be used to study obesity and metabolic disorders.